Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice

Tsuneki, H; Sugiyama, M; Sato, K; Ito, H; Nagai, S; Kon, K; Wada, T; Kobayashi, N; Okada, T; Toyooka, N; Kawasaki, M; Ito, T; Otsubo, R; Okuzaki, D; Yasui, T; Sasaoka, T

Tsuneki, H; Sasaoka, T (通讯作者)，Univ Toyama, Dept Clin Pharmacol, 2630 Sugitani, Toyama 9300194, Japan.

EUROPEAN JOURNAL OF PHARMACOLOGY, 2023; 961 ():

Abstract

Sleep disorders are associated with increased risk of obesity and type 2 diabetes. Lemborexant, a dual orexin receptor antagonist (DORA), is clinicall......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索